Dibucaine
Dibucaine is a local anesthetic of the amide type now generally used for surface anesthesia. (In Vitro) :Dibucaine (Cinchocaine) reduces the degradation of BSA-gold complex in the reservosomes, which was not caused either by an inhibition of the whole proteolytic activity of the parasite or by a reduction on the expression levels of cruzipain. Dibucaine, a quaternary ammonium compound, inhibited SChE to a minimum within 2 min in a reversible manner. The inhibition was very potent. It had an IC (50) of 5.3 microM with BuTch or 3.8 microM with AcTch. The inhibition was competitive with respect to BuTch with a K (i) of 1.3 microM and a linear-mixed type (competitive/noncompetitive) with respect to AcTch with inhibition constants, K (i) and K (I) of 0.66 and 2.5 microM, respectively. Dibucaine possesses a butoxy side chain that is similar to the butryl group of BuTch and longer by an ethylene group from AcTch.
Product Specifications
CAS Number
85-79-0
Product Name Alternative
NSC 159055
Purity
>98% (HPLC)
Solubility
Water: 42 mg/L (at 21 °C)
Smiles
CCCCOC1=NC2=CC=CC=C2C (=C1) C (=O) NCCN (CC) CC
Molecular Formula
C20H29N3O2
Molecular Weight
343.46
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
2-butoxy-N-[2- (diethylamino) ethyl]quinoline-4-carboxamide
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog